[go: up one dir, main page]

ES2004268A6 - Procedimiento para preparar nuevos esteroides en un ciclo espiranico en posicion 17 - Google Patents

Procedimiento para preparar nuevos esteroides en un ciclo espiranico en posicion 17

Info

Publication number
ES2004268A6
ES2004268A6 ES8700832A ES8700832A ES2004268A6 ES 2004268 A6 ES2004268 A6 ES 2004268A6 ES 8700832 A ES8700832 A ES 8700832A ES 8700832 A ES8700832 A ES 8700832A ES 2004268 A6 ES2004268 A6 ES 2004268A6
Authority
ES
Spain
Prior art keywords
formula
spiranic
cycle
product
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700832A
Other languages
English (en)
Inventor
Francois Nique
Lucien Nedelec
Daniel Philibert
Martine Moguilewsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES2004268A6 publication Critical patent/ES2004268A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR NUEVOS ESTEROIDES CON UN CICLO ESPIRANICO EN POSICION 17 DE FORMULA:DONDE R1=ARILO, ARALQUILO, EVENTUALMENTE SUSTITUIDOS; R2=RADICAL HIDROCARBONADO C1-18 CON DOBLE ENLACE EVENTUAL EN 3'', 4''; A, B REPRESENTANDONDE R'' Y R''K=H O ALQUILO C1-4 Y RE=H, ALQUILO C1-6 EVENTUALMENTE SUSTITUIDO O ACILO, O A, B, C REPRESENTANEN QUE SE SOMETE UN PRODUCTO DE FORMULA:DONDE K=GRUPO PROTECTOR, A LA ACCION DE UN REACTIVO DE CICLISACION PARA OBTENER PRODUCTOS DE FORMULA:QUE SE SOMETEN A UN REACTIVO DE DESHIDRATACION SUSCEPTIBLE DE LIBERAR LA FUNCION CETONA PARA OBTENER UN PRODUCTO DE FORMULA:DONDE R''=R''K=H, O BIEN OBTENER DIRECTAMENTE DICHO PRODUCTO IA, QUE, SI SE DESEA, SE SOMETE A REACCIONES SUBSIGUIENTES PARA OBTENER LOS DEMAS PRODUCTOS DE FORMULA I. LOS COMPUESTOS OBTENIDOS SON UTILES COMO AGENTES ANTIPROGESTOMIMETICOS.
ES8700832A 1986-03-26 1987-03-25 Procedimiento para preparar nuevos esteroides en un ciclo espiranico en posicion 17 Expired ES2004268A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8604355A FR2596395B1 (fr) 1986-03-26 1986-03-26 Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant

Publications (1)

Publication Number Publication Date
ES2004268A6 true ES2004268A6 (es) 1988-12-16

Family

ID=9333576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700832A Expired ES2004268A6 (es) 1986-03-26 1987-03-25 Procedimiento para preparar nuevos esteroides en un ciclo espiranico en posicion 17

Country Status (27)

Country Link
US (1) US4900725A (es)
EP (1) EP0262188B1 (es)
JP (2) JP2684180B2 (es)
KR (1) KR880701244A (es)
CN (1) CN1021445C (es)
AU (1) AU604692B2 (es)
CA (1) CA1299169C (es)
DK (1) DK174211B1 (es)
ES (1) ES2004268A6 (es)
FI (1) FI87078C (es)
FR (1) FR2596395B1 (es)
GR (1) GR870471B (es)
HU (1) HU198509B (es)
IE (1) IE60143B1 (es)
IL (1) IL82004A0 (es)
MA (1) MA20918A1 (es)
MX (1) MX5712A (es)
NZ (1) NZ219776A (es)
OA (1) OA08505A (es)
PH (1) PH25612A (es)
PT (1) PT84554B (es)
SU (1) SU1715205A3 (es)
TN (1) TNSN87042A1 (es)
TR (1) TR23117A (es)
WO (1) WO1987005908A1 (es)
YU (1) YU53387A (es)
ZA (1) ZA872130B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
FR2651233B1 (fr) * 1989-08-23 1991-12-13 Roussel Uclaf Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
IL115659A (en) * 1994-10-27 2000-06-01 Akzo Nobel Nv Steroids with a 17-spiromethylene lactone or lactol group process for their preparation and pharmaceutical compositions containing them
FR2757399B1 (fr) * 1996-12-23 1999-12-17 Hoechst Marion Roussel Inc Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
FR2789393B1 (fr) * 1999-02-05 2001-10-12 Centre Nat Rech Scient Lactol steroidique
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
GB0711948D0 (en) * 2007-06-20 2007-08-01 Bionature E A Ltd Neurosteriod compounds
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
AU2010293960B2 (en) * 2009-09-11 2015-03-19 Bionature E.A. Ltd. Use of steroid compounds for inflammatory and autoimmune disorders
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509135A (en) * 1968-07-26 1970-04-28 Searle & Co 3-oxygenated 4'-5 - dihydrospiro(estra-4,9-diene-17,2'(3'h)-furans) and congeners
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
FR2496669A1 (fr) * 1980-12-23 1982-06-25 Roussel Uclaf Nouveaux derives steroides 3-ceto4 ou1-4 substitues en position 7, leur procede de preparation et leur application comme medicaments
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene

Also Published As

Publication number Publication date
DK174211B1 (da) 2002-09-23
YU53387A (en) 1988-08-31
KR880701244A (ko) 1988-07-26
DK618287A (da) 1988-01-22
IL82004A0 (en) 1987-10-20
OA08505A (fr) 1988-07-29
CN1021445C (zh) 1993-06-30
AU604692B2 (en) 1991-01-03
PT84554A (fr) 1987-04-01
IE60143B1 (en) 1994-06-01
JP2684180B2 (ja) 1997-12-03
IE870772L (en) 1987-09-26
MX5712A (es) 1993-11-01
FI875202A0 (fi) 1987-11-25
JPH08311094A (ja) 1996-11-26
JPS63502902A (ja) 1988-10-27
HUT46037A (en) 1988-09-28
TNSN87042A1 (fr) 1990-01-01
HU198509B (en) 1989-10-30
CN87103193A (zh) 1988-01-13
FR2596395B1 (fr) 1989-05-26
NZ219776A (en) 1990-03-27
PH25612A (en) 1991-08-08
US4900725A (en) 1990-02-13
EP0262188B1 (fr) 1990-11-14
JP2652007B2 (ja) 1997-09-10
FR2596395A1 (fr) 1987-10-02
FI875202L (fi) 1987-11-25
PT84554B (pt) 1989-11-10
FI87078B (fi) 1992-08-14
EP0262188A1 (fr) 1988-04-06
WO1987005908A1 (fr) 1987-10-08
TR23117A (tr) 1989-04-03
FI87078C (fi) 1992-11-25
SU1715205A3 (ru) 1992-02-23
AU7167487A (en) 1987-10-20
MA20918A1 (fr) 1987-10-01
ZA872130B (en) 1988-05-25
GR870471B (en) 1987-07-30
CA1299169C (fr) 1992-04-21
DK618287D0 (da) 1987-11-25

Similar Documents

Publication Publication Date Title
ES2004268A6 (es) Procedimiento para preparar nuevos esteroides en un ciclo espiranico en posicion 17
ES2000534A6 (es) Un procedimiento para preparar nuevos compuestos de piridina
ES8704481A1 (es) Procedimiento para la preparacion de nuevos derivados de pi-colina
BR8506446A (pt) Composicao aquosa de peroxido de hidrogenio,processo para inibir a decomposicao de peroxido de hidrogenio e processo para a preparacao de uma composicao
BR7900156A (pt) Produto detergente,desodorizante e seu processo de preparacao
ES2067036T3 (es) Productos de alcoxilacion de derivados de acidos carboxilicos y/o acidos carboxilicos que contienen grupos oh.
MX5836E (es) Procedimiento para preparar derivados de acidos-5-tiazol-carboxilicos 2,4-disubstituidos
KR870000103A (ko) 산화촉매의 제조방법
ES2039195T3 (es) Derivado de la pirazolsulfonamida, procedimiento para su fabricacion y herbicida que lo contiene.
GB2021141A (en) Concentrated aqueous surfactant compositions
BR8906227A (pt) Processo para preparar benzeno 3,4-difluoro substituido
EP0012570A3 (en) Selective reaction of 1,4-disubstituted benzene compounds
ES2001405A6 (es) Un procedimiento para la preparacion de derivados de 4-aminofenilo sustituidos
DD134091A5 (de) Verfahren zur herstellung von 1,3,5-triazin-2,6-dionen
BR8700701A (pt) Processo para a fabricacao de hidroxilaminas n,n-dissubstituidas,e,respectivas hidroxilaminas
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
FR2609037B1 (fr) Nouveau polyimide contenant des motifs indane, son procede de preparation et son utilisation en tant qu'adhesif
ATE93828T1 (de) Auf polyphenylmethanen basierende zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung als dielektrikum.
PT82837B (pt) Processo para a preparacao de esteroido {3,2-c} pirazois uteis como agentes anti-androgenios
ES2023124B3 (es) Aprestos para textiles.
DE3572648D1 (en) Halogen labeled compounds including estradiol derivatives, their synthetic intermediates and the syntheses thereof
DK0452085T3 (da) Fremgangsmåde til fremstilling af methylaminer
ATE2895T1 (de) Verfahren zur herstellung von 4-hydroxy-carbazol.
ATE17228T1 (de) Verfahren zur oxydation von vinylbenzenverbindungen zu beta-phenylaldehyden.
FR2376692A1 (fr) Procede de neutralisation de produits reactionnels basiques